Company Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.
It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.
Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
| Country | United States |
| Founded | 1986 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 524 |
| CEO | Paul Josephs |
Contact Details
Address: 3515 Lyman Boulevard Chaska, Minnesota 55318 United States | |
| Phone | (952) 368-4300 |
| Website | lifecore.com |
Stock Details
| Ticker Symbol | LFCR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0001005286 |
| ISIN Number | US5147661046 |
| Employer ID | 94-3025618 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Paul Josephs | President, Chief Executive Officer and Director |
| James G. Hall | Advisor |
| Ryan D. Lake CPA | Executive Vice President and Chief Financial Officer |
| Thomas Guldager | Senior Vice President of Operations |
| Thomas Salus | Chief Legal and Administration Officer and Corporate Secretary |
| Aaron Perlitsh | Director of Internal Audit and Chief Compliance Officer |
| Jackie Q. Klecker | Executive Vice President of Quality and Development Services |
| Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. |
| Parker K. Javid | Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2025 | 8-K | Current Report |
| Apr 10, 2025 | 8-K | Current Report |
| Apr 3, 2025 | 10-Q | Quarterly Report |
| Apr 3, 2025 | 8-K | Current Report |
| Feb 27, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 5, 2025 | SCHEDULE 13G/A | Filing |
| Jan 21, 2025 | PRE 14A | Other preliminary proxy statements |
| Jan 17, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |